Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Parolaro

Showing results (21-30 of 81) with videos related to

Pageof 9
Sort By:
Neuroreport|November 14, 1997
Modulation of rat brain cannabinoid receptors after chronic morphine treatmentT Rubino, L Tizzoni, D Viganò, et al.
The European Journal of Neuroscience|November 1, 1995
Morphine withdrawal syndrome and G protein expression: a study of the time course in the rat central nervous systemT Rubino, M Parenti, G Patrini, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 1997
Cholera toxin effects on body temperature changes induced by morphineL Basilico, M Parenti, A Fumagalli, et al.
Synapse (New York, N.Y.)|December 1, 1999
In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatmentsT Rubino, D Viganò, E Zagato, et al.
Veterinary Immunology and Immunopathology|October 6, 2001
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophagesW Ponti, T Rubino, M Bardotti, et al.
Pharmacological Research|November 1, 1989
Central pertussis toxin abolishes the intestinal inhibition induced by intracerebroventricular morphineP Massi, G Patrini, T Rubino, et al.
Pharmacological Research|January 1, 1989
Effect of intracerebroventricular administration of histamine upon intestinal motility in ratsD Parolaro, G Patrini, P Massi, et al.
European Journal of Pharmacology|January 29, 2000
Relative involvement of cannabinoid CB(1) and CB(2) receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activityP Massi, D Fuzio, D Viganò, et al.
Life Sciences|June 2, 2000
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndromeT Rubino, P Massi, D Viganò, et al.
European Journal of Pharmacology|August 17, 1999
Cross-tolerance and convergent dependence between morphine and cannabimimetic agent WIN 55,212-2 in the guinea-pig ileum myenteric plexusL Basilico, D Parolaro, M Colleoni, et al.
Pageof 9

Showing results (21-30 of 81) with videos related to

Sort By:
Pageof 9
Neuroreport|November 14, 1997
Modulation of rat brain cannabinoid receptors after chronic morphine treatmentT Rubino, L Tizzoni, D Viganò, et al.
The European Journal of Neuroscience|November 1, 1995
Morphine withdrawal syndrome and G protein expression: a study of the time course in the rat central nervous systemT Rubino, M Parenti, G Patrini, et al.
Pharmacology, Biochemistry, and Behavior|March 1, 1997
Cholera toxin effects on body temperature changes induced by morphineL Basilico, M Parenti, A Fumagalli, et al.
Synapse (New York, N.Y.)|December 1, 1999
In vivo characterization of the specific cannabinoid receptor antagonist, SR141716A: behavioral and cellular responses after acute and chronic treatmentsT Rubino, D Viganò, E Zagato, et al.
Veterinary Immunology and Immunopathology|October 6, 2001
Cannabinoids inhibit nitric oxide production in bone marrow derived feline macrophagesW Ponti, T Rubino, M Bardotti, et al.
Pharmacological Research|November 1, 1989
Central pertussis toxin abolishes the intestinal inhibition induced by intracerebroventricular morphineP Massi, G Patrini, T Rubino, et al.
Pharmacological Research|January 1, 1989
Effect of intracerebroventricular administration of histamine upon intestinal motility in ratsD Parolaro, G Patrini, P Massi, et al.
European Journal of Pharmacology|January 29, 2000
Relative involvement of cannabinoid CB(1) and CB(2) receptors in the Delta(9)-tetrahydrocannabinol-induced inhibition of natural killer activityP Massi, D Fuzio, D Viganò, et al.
Life Sciences|June 2, 2000
Long-term treatment with SR141716A, the CB1 receptor antagonist, influences morphine withdrawal syndromeT Rubino, P Massi, D Viganò, et al.
European Journal of Pharmacology|August 17, 1999
Cross-tolerance and convergent dependence between morphine and cannabimimetic agent WIN 55,212-2 in the guinea-pig ileum myenteric plexusL Basilico, D Parolaro, M Colleoni, et al.
Pageof 9